Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mexico has a little over a third of the US population 126 million people
https://www.leafly.com/news/politics/mexico-is-moving-to-legalize-cannabis-in-2021-what-does-that-mean-for-the-us
https://seekingalpha.com/news/3663300-gamestop-hearing-on-tap-with-robinhood-melvin-reddit-and-citadel-ceos?utm_medium=email&utm_source=seeking_alpha
I think this did a lot of damage to small investors in stocks like Cronos. It is my humble opinion.
In this article it is said (see table) that Cronos (special articles related to Cronos) contributed 51 million after taxes to Altria. Can I assume that if Altria made $ 51 million at 45%, Cronos' earnings last year were $ 113 million? Or is it wrong of me to assume that?
https://finance.yahoo.com/news/altria-presents-part-consumer-analyst-140000706.html
Completely agree with you. My wait is based on what they will do with the outcome of the Ginkgo deal. I believe that September is the goal to have results in this matter, with which I consider that by March 2022 we should see that result materialize in the value of the stock. I would like to see business in Europe, in Mexico, growth in Israel and Australia. The world is bigger than the US. But beyond all, I think investors need to see what they are doing. This is just my opinion.
we will continue to wait ...
?
Yes it is by far the least newsworthy. Sitting on a pile of money ... but I can't help but believe in its potential.
That's without taking into account the Ginkgo agreement to obtain Synthetic Cannabinoids. The Cronos price at the moment is really a bargain. Imho.
The only thing missing is that ACB has a fatal ER to end up sinking us. ACB never contributes anything to the sector.
Yes, i agree. The crash is incredible ... well I've been here for a long time, I'll keep waiting ... I'm not going to sell.
February earnings lost in one day...
Yes, you are right. If we compare where they were in 2019 and where they are today, certainly the one that lost the least value was Cronos. I was referring a little to how fast ACB rose compared to the same price of Cronos a few months ago where they were the same. But like Tilray, ACB was hit hard, so it is reasonable that it grows faster.
News... I just have to say that I am impressed that we are not priced higher.
This is what we need, news ... thanks for sharing.
Many people forget the pharmaceutical sector ... you can smoke as much as you want or not ... but everyone needs medicine.
https://mjbizdaily.com/gw-pharmaceuticals-sale-might-spur-pharma-cannabis-deal-making/
Yes, even ACB that is already above Cronos costs much less. I don't trust Gorenstein's PR because they have historically collapsed the stock price. The big problem with Cronos is that it is still valued based on its production and sales capacity, and that has never really been Cronos' business. I think the only thing that can get this action to where it should be is the news from the laboratory and I think that until September we will not know anything. For those of us who have relied on Cron, times like these are disappointing to see couples as bad as ACB above. Even Aphria's valuation is still bad when you compare it to ACB. And that Cronos is below ACB seems incredible to me. It really shows that these are news stocks, and very young people, many of them reluctant to read and research, and consequently end up buying what the pack buys. On the other hand, have you noticed that there are no MF articles? I find it so strange that there is no "shorts" campaign at the moment ... my humble opinion, just that.
The market has been unfair to Cronos. Among ACB, Aphria, Tilray and CGC right now it is the one with the lowest valuation. And Cronos has a more solid track record and with fewer scandals than the others. It is my humble opinion, I think it is still undervalued.
Yes.
The best I've read on this board in all these years. Thanks for sharing.
9.76,maybe?
This continues to fall, it seems that the excitement of investors has already disappeared
Let's hope so, I don't see good reasons for this to happen. Even less when Cronos does not have the problems of ACB.
I agree. But, Unfortunately, what happens to ACB weighs down all of the weed stock. Take a look at today's chart and see how Cronos moves like ACB. ACB has given the sector a bad name.
Thanks, it's great.
Yes, finally!
Probably. Happy New Year!
Well the gains for November and December were lost. We will see next year that brings us, but really the serious market is not interested in these companies. Here there are only opportunists who pump this up and then drop it. I wish you all a happy new year and may we all get money out of this investment.
Yes. Two steps forward, one step back.
Well, 2022. Another year under 10$. Red day...
Apparently yes!
LOL!
Yes, good!
Apparently we are seeing a major correction. The $ 12 dream seems to be fading. Will we see $ 6 again?
Apparently the stock does not want to go higher. It seems that the rally only got here, and perhaps we will again see valuations in the order of $ 6. What do you think?
Can you explain what this has to do with CRON?
I really appreciate this type of post, they are the things that I hope to read when I come to this board. thank you very much